San Francisco, California
London, United Kingdom
Some of the most successful CEOs and company founders in the industry will come together for a candid discussion on the trends in life science investing. These premier speakers will share insights into where they have secured funding in the past, what to avoid when attempting to raise capital, and who they would recommend partnering with in order to flourish. Their track records in building groundbreaking and successful businesses speak for themselves – so join us for what will be not only be an informative and entertaining panel discussion, but a great chance to close out the year and spread a little holiday cheer.
In addition to this panel discussion, there will also be an opportunity to donate items to Rosie's Place, a local charity.
Katrine Bosley | Entrepreneur-in-residence, Broad Institute
Richard Heyman | CEO, Seragon Pharmaceuticals
Paulina Hill | Senior Associate, Polaris Venture Partners
Joseph Payne | Founder, President & CEO, Arcturus Therapeutics
Merv Turner | Former CSO, Merck [moderator]
3:00pm | Registration & Networking
3:30pm | Introductions
3:35pm | Panel Presentation
5:00pm | Networking Reception
6:30pm | Close
$40 General Public
When & Where
JLABS, part of Johnson & Johnson Innovation, LLC, is a network of life science incubators providing emerging companies many of the advantages of being in a big company, without the capital investment. JLABS offers singular bench tops, modular wet lab units and office space on a short-term basis, allowing companies to pay only for the space they need, with an option to quickly expand when they have the resources to do so. Companies residing at JLABS also have access to core research labs hosting specialized capital equipment and shared administrative areas. JLABS is an open innovation model, and the agreement for space does not grant JLABS or Johnson & Johnson Innovation any stake or rights in the companies, nor will the companies have a guaranteed future affiliation with JLABS. The flagship facility is located in San Diego at Janssen's West Coast Research Center, and JLABS has now two established locations in San Francisco - one through a collaboration with the California Institute for Quantitative Biosciences (QB3) and a second standalone facility - one in Boston through a collaboration with Lab Central, one in Houston through a collaboration with TMC, and one in Toronto through a collaboration with MaRS. For more information please visit jlabs.jnjinnovation.com.